TY - JOUR
T1 - Comparison of practice-related changes in dual task walking performance and neural efficiency between older adults with progressive and relapsing-remitting multiple sclerosis
AU - Hernandez, Manuel E.
AU - Motl, Robert W.
AU - Foley, Frederick W.
AU - Izzetoglu, Meltem
AU - Wagshul, Mark
AU - Holtzer, Roee
N1 - This research was supported by grants from the National Institutes of Health (R01NS109023). The funding source had no involvement in the study design; in collection, analysis and interpretation of data; in writing of the report; and in the decision to submit the article for publication.
PY - 2025/1
Y1 - 2025/1
N2 - Background: There is limited research comparing both performance and brain control of walking between older adults with progressive and relapsing-remitting MS. Objective: This study compared older adults with progressive and relapsing-remitting MS for differences in prefrontal cortex (PFC) activation in single- and dual-task-walking and practice-related effects on neural efficiency, walking, and cognitive performances. Methods: Older adults with progressive (n = 32, age=65±6ys) and relapsing-remitting (n = 63, age=65±4ys) MS completed three conditions (single-task walk, single-task-alpha, i.e., cognitive interference task, and dual-task-walk) with three repeated trials wherein we measured PFC oxygenated hemoglobin (HbO2), stride velocity and letter generation rate. Task, trial, and group effects and interactions were analyzed using linear mixed effects models. Results: The task-related (i.e. single-to-dual task walking) increase in PFC HbO2 was greater in progressive than in relapsing-remitting MS (p < 0.001), while the practice-related decrease in dual-task PFC HbO2 was smaller in progressive than in relapsing-remitting MS (p < 0.001). Progressive MS was associated with slower stride velocity overall, but repeated trials resulted in faster stride velocity and correct letter generation rate for both groups. Conclusions: Practice-related improvements in cognitive and motor performances coupled with reduced PFC HbO2 over dual-task walking trials suggest attenuated improvements of efficiency in brain control of attention-demanding locomotion in progressive MS.
AB - Background: There is limited research comparing both performance and brain control of walking between older adults with progressive and relapsing-remitting MS. Objective: This study compared older adults with progressive and relapsing-remitting MS for differences in prefrontal cortex (PFC) activation in single- and dual-task-walking and practice-related effects on neural efficiency, walking, and cognitive performances. Methods: Older adults with progressive (n = 32, age=65±6ys) and relapsing-remitting (n = 63, age=65±4ys) MS completed three conditions (single-task walk, single-task-alpha, i.e., cognitive interference task, and dual-task-walk) with three repeated trials wherein we measured PFC oxygenated hemoglobin (HbO2), stride velocity and letter generation rate. Task, trial, and group effects and interactions were analyzed using linear mixed effects models. Results: The task-related (i.e. single-to-dual task walking) increase in PFC HbO2 was greater in progressive than in relapsing-remitting MS (p < 0.001), while the practice-related decrease in dual-task PFC HbO2 was smaller in progressive than in relapsing-remitting MS (p < 0.001). Progressive MS was associated with slower stride velocity overall, but repeated trials resulted in faster stride velocity and correct letter generation rate for both groups. Conclusions: Practice-related improvements in cognitive and motor performances coupled with reduced PFC HbO2 over dual-task walking trials suggest attenuated improvements of efficiency in brain control of attention-demanding locomotion in progressive MS.
KW - Multiple sclerosis
KW - Progressive
KW - Walking, Cognition, Functional-near-infrared-spectroscopy
UR - http://www.scopus.com/inward/record.url?scp=85212085833&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85212085833&partnerID=8YFLogxK
U2 - 10.1016/j.msard.2024.106224
DO - 10.1016/j.msard.2024.106224
M3 - Article
C2 - 39693703
AN - SCOPUS:85212085833
SN - 2211-0348
VL - 93
JO - Multiple Sclerosis and Related Disorders
JF - Multiple Sclerosis and Related Disorders
M1 - 106224
ER -